PDS Biotechnology (PDSB) Tops Q3 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
Tweet
Share
E-mailGet Alerts PDSB Hot Sheet
Join SI Premium – FREE
PDS Biotechnology (NASDAQ: PDSB) reported Q3 EPS of ($0.29), $0.01 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on PDS Biotechnology (PDSB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Crown Holdings (CCK) Tops Q3 EPS by 13c; offers guidance
- Bitdeer reports 200% Bitcoin output rise, $2.9B AI backlog
- RBB Bancorp (RBB) Tops Q3 EPS by 16c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
